ReviewCureus2024
Effect of Preoperative Corticosteroid Injections on Postoperative Risk of Periprosthetic Joint Infection and Revision Surgery After Total Shoulder Arthroplasty: A Systematic Review and Meta-Analysis.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In total joint arthroplasty, periprosthetic joint infection (PJI) can be devastating. Corticosteroid injections (CSIs) are commonly administered for temporary pain relief in the setting of various conditions. Therefore, the current systematic review aims to evaluate whether CSIs administered prior to total shoulder arthroplasty (TSA) are a risk factor for PJI and revision surgery. A search following guidelines established by the Preferred Reporting Items for Systematic Reviews and Meta-analyses was performed in the PubMed, Embase, and Scopus databases to identify studies evaluating outcomes in patients receiving CSIs prior to TSA. A meta-analysis comparing the risk of PJI between patients receiving CSIs at various time points versus those with no CSIs was performed. Seven studies comprising 49,786 patients who received CSIs were included. Most studies reported significantly higher odds of PJI and revision surgery when CSIs were administered within three months of TSA. The results of the meta-analysis found the risk of PJI was significantly higher when CSIs were administered within three months of TSA (risk ratio (RR): 1.12, 95% confidence interval (CI): 1.04-1.20, P = 0.002) but not greater than three months prior to TSA (RR: 1.02, 95% CI: 0.80-1.30, P = 0.85), relative to a control group undergoing TSA with no prior CSIs. Several studies have demonstrated that CSIs are associated with increased risks of PJI and revision surgery. A safe interval between CSI and subsequent TSA, to minimize the risk of PJI and revision surgery, appears to be around one to three months, with three months being the safest time period, as supported by the findings of our meta-analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.